B. Braun Medical Inc.

B. Braun Medical Inc., a for-profit medical device and pharmaceutical equipment manufacturer headquartered in Bethlehem, Pennsylvania, is a wholly owned subsidiary of Central Admixture Pharmacy Services, Inc. and sells hemodialysis maintenance services, total parenteral nutrition (TPN) compounders, water treatment systems, and pharmaceutical preparation manufacturing to the Department of Veterans Affairs and the Defense Health Agency as a prime contractor under full-and-open competition with no set-aside designations.

B. Braun operates exclusively as a prime contractor — the vendor_award_portfolio shows 100% prime awards with zero subcontract activity. The company competes without SBA certifications or set-aside protections; all recent awards carry no set-aside designations and are issued through firm fixed-price purchase orders and definitive contracts on unrestricted full-and-open solicitations, with evaluation weighted toward technical capability and past performance. The vendor's federal footprint is massive but heavily concentrated in transactional purchase orders: 15,408 total awards (first award 1987) with $10.12 billion in combined potential value, though only $49.1 million has been obligated to date, reflecting the portfolio's structure as a long-tail supply relationship rather than high-revenue programs.

Customer concentration sits almost entirely within the Veterans Health Administration. The Department of Veterans Affairs Veterans Integrated Service Network 22 leads by award count (103 awards, $8.8 million combined potential value) and is closely tracked by VISN 9 (60 awards, $492 thousand), the broader Department of Veterans Affairs (55 awards, $726 thousand), VISN 17 (44 awards, $1.8 million), and the Navy Bureau of Medicine and Surgery (34 awards, $468 thousand). By dollar ranking, VISN 12 dominates ($27.3 million across 18 awards), followed by VISN 22 and VISN 17. Recent representative prime work includes a $413,228 five-year maintenance contract with VISN 8 for hemodialysis systems and water treatment equipment (July 2026), a $492,108 five-year preventative and corrective maintenance contract with VISN 17 for Dialog+ and Dialog+ Evolution dialysis units at Audie L. Murphy Memorial Veterans Hospital in San Antonio (September 2024, unrestricted full-and-open under NAICS 811210), a $284,544 four-year preventative maintenance contract with VISN 21 for Dialog+ equipment at VA Palo Alto (April 2023, sole source with five-year experience requirement), and a $129,000 five-year compounder lease with the Defense Health Agency at Womack Army Medical Center, Fort Liberty, North Carolina (April 2023).

B. Braun's work spans three dominant product lines: pharmaceutical preparation manufacturing (3,638 awards under NAICS 325411) and surgical and medical instrument manufacturing (3,176 awards under NAICS 339112) account for the highest award volumes, with medical equipment merchant wholesaling (359 awards) and equipment repair and maintenance (57 awards) rounding out the NAICS footprint. By PSC code, medical and surgical instruments and supplies dominate at 10,670 awards, followed by drugs and biologicals (2,651 awards) and hospital furniture and equipment (999 awards). Performance locations span the continental United States with significant VA facility concentration in Dallas, Phoenix, San Antonio, Palo Alto, Philadelphia, Tampa, Salt Lake City, Buffalo, and Seattle, plus Defense Health Agency presence at military treatment facilities. Activity shows modest growth year-over-year — two awards in 2022 to eight in 2025 — with only five awards ($596 thousand combined potential value) reaching ultimate completion in the next twenty-four months, indicating minimal recompete exposure in that window. The vendor places the vast majority of its work under two Federal Supply Schedules: V797P4337A (3,120 task orders, $19.9 million combined potential value) and V797P5365X (3,513 task orders, $6 million combined potential value), plus smaller volumes under blanket purchase agreements with the VA.